dc.creatorSANTOS, N. A. G.
dc.creatorMEDINA, W. S. G.
dc.creatorMARTINS, N. M.
dc.creatorRODRIGUES, M. A. Carvalho
dc.creatorCURTI, C.
dc.creatorSANTOS, A. C.
dc.date.accessioned2012-10-19T03:39:52Z
dc.date.accessioned2018-07-04T14:57:04Z
dc.date.available2012-10-19T03:39:52Z
dc.date.available2018-07-04T14:57:04Z
dc.date.created2012-10-19T03:39:52Z
dc.date.issued2008
dc.identifierTOXICOLOGY IN VITRO, v.22, n.8, p.1820-1824, 2008
dc.identifier0887-2333
dc.identifierhttp://producao.usp.br/handle/BDPI/19921
dc.identifier10.1016/j.tiv.2008.08.004
dc.identifierhttp://dx.doi.org/10.1016/j.tiv.2008.08.004
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1616706
dc.description.abstractThe use of the classic aromatic antiepileptic drugs (AAEDs) has recently been expanded to a broad spectrum of psychiatric and neurological disorders. However, the clinical use of these drugs is limited by several adverse effects, mainly idiosyncratic hepatotoxicity. AAED-induced hepatotoxicity has been attributed to a defective detoxification by the epoxide hydrolase and accumulation of arene oxides. The underlying mechanism has been proposed as immune-mediated, but direct toxicity has also been suggested. In general, idiosyncratic drug-induced hepatotoxicity may be mediated, at least in part, by oxidative stress. On the other hand, the oxidative stress induced by the AAED metabolites has not been demonstrated yet. Therefore, in the present study we have evaluated the induction of oxidative stress by three classical AAEDs: carbamazepine. phenytoin and phenobarbital as well as by their metabolites. The toxic effects of the metabolites were evaluated by incubating the drug with rat liver microsomes. The AAED-induced oxidative stress was demonstrated by the increased malondialdehyde levels, oxidation of cardiolipin; oxidation of sulfhydryl proteins and alteration of the cellular redox status. Results suggest that the hepatotoxicity associated with AAED might be mediated by the oxidative stress induced by the drugs metabolites. (C) 2008 Elsevier Ltd. All rights reserved
dc.languageeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.relationToxicology in Vitro
dc.rightsCopyright PERGAMON-ELSEVIER SCIENCE LTD
dc.rightsrestrictedAccess
dc.subjectCarbamazepine
dc.subjectPhenobarbital
dc.subjectPhenytoin
dc.subjectArene oxides
dc.subjectHepatotoxicity
dc.subjectOxidative stress
dc.subjectMitochondria
dc.subjectAromatic antiepileptic drugs
dc.subjectBioactivation
dc.titleInvolvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución